Third Affiliated Hospital, Sun Yat-sen University
Clinical trials sponsored by Third Affiliated Hospital, Sun Yat-sen University, explained in plain language.
-
New blood filter shows promise for liver failure patients with sepsis
Disease control Recruiting nowThis study tests a new blood-filtering method (DPCAS+LPE) in 192 adults with acute-on-chronic liver failure and sepsis. The goal is to see if it lowers death rates at 4 and 12 weeks compared to standard plasma exchange. Participants receive two sessions of the therapy, and resear…
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Massive hospital study aims to find and treat hidden hepatitis b cases
Disease control Recruiting nowThis study involves 16,300 people with chronic hepatitis B across three hospitals. The goal is to increase the number of patients referred to liver specialists and started on antiviral treatment. Researchers will also track how antiviral therapy affects patients' quality of life …
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for MS patients: real-world study tests ofatumumab's impact on nerve damage
Disease control Recruiting nowThis study looks at how well the drug ofatumumab works for people with relapsing multiple sclerosis (RMS) in everyday medical practice. It will measure changes in a blood marker called sNfL, which indicates nerve damage. About 80 adults with RMS will take ofatumumab and be follow…
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated May 06, 2026 16:03 UTC